Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel

Angiogenesis is critical to the growth of tumors. Vascularization-targeting agents, with or without cytotoxic drugs, are widely used for the treatment of several solid tumors including esophagogastric adenocarcinoma. However, little is known about the systemic effects of anti-angiogenic therapies an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drug Deliv
Egile Nagusiak: Steins, Anne, Ebbing, Eva A., Pistorius, Marcel C. M., Waasdorp, Cynthia, Krishnadath, Kausilia K., Medema, Jan Paul, Wilmink, Johanna W., Mathôt, Ron A. A., Bijlsma, Maarten F., van Laarhoven, Hanneke W. M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8241153/
https://ncbi.nlm.nih.gov/pubmed/29172757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2017.1406559
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak